Literature DB >> 27313321

The potential of a single enhancer.

Elisabeth F Heuston1.   

Abstract

Mesh：

Year:  2016        PMID： 27313321      PMCID： PMC4911860          DOI： 10.1182/blood-2016-03-706218

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.

Authors:  D E Zhang; P Zhang; N D Wang; C J Hetherington; G J Darlington; D G Tenen
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  The role of different genetic subtypes of CEBPA mutated AML.

Authors:  A Fasan; C Haferlach; T Alpermann; S Jeromin; V Grossmann; C Eder; S Weissmann; F Dicker; A Kohlmann; S Schindela; W Kern; T Haferlach; S Schnittger
Journal:  Leukemia       Date:  2013-09-23       Impact factor: 11.528

3.  Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.

Authors:  Hong Guo; Ou Ma; Nancy A Speck; Alan D Friedman
Journal:  Blood       Date:  2012-03-26       Impact factor: 22.113

4.  AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

Authors:  T Pabst; B U Mueller; N Harakawa; C Schoch; T Haferlach; G Behre; W Hiddemann; D E Zhang; D G Tenen
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

5.  A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.

Authors:  Martin Jinek; Krzysztof Chylinski; Ines Fonfara; Michael Hauer; Jennifer A Doudna; Emmanuelle Charpentier
Journal:  Science       Date:  2012-06-28       Impact factor: 47.728

Review 6.  C/EBPα in normal and malignant myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2015-03-10       Impact factor: 2.490

7.  Impaired energy homeostasis in C/EBP alpha knockout mice.

Authors:  N D Wang; M J Finegold; A Bradley; C N Ou; S V Abdelsayed; M D Wilde; L R Taylor; D R Wilson; G J Darlington
Journal:  Science       Date:  1995-08-25       Impact factor: 47.728

8.  An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.

Authors:  Roberto Avellino; Marije Havermans; Claudia Erpelinck; Mathijs A Sanders; Remco Hoogenboezem; Harmen J G van de Werken; Elwin Rombouts; Kirsten van Lom; Paulina M H van Strien; Claudia Gebhard; Michael Rehli; John Pimanda; Dominik Beck; Stefan Erkeland; Thijs Kuiken; Hans de Looper; Stefan Gröschel; Ivo Touw; Eric Bindels; Ruud Delwel
Journal:  Blood       Date:  2016-03-10       Impact factor: 22.113

9.  Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis.

Authors:  T Pabst; M Eyholzer; J Fos; B U Mueller
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640
  9 in total
  1 in total

Review 1.  Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia.

Authors:  Cristina Panuzzo; Elisabetta Signorino; Chiara Calabrese; Muhammad Shahzad Ali; Jessica Petiti; Enrico Bracco; Daniela Cilloni
Journal:  J Clin Med       Date:  2020-03-16       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.